01 2Merck Canada Inc.
02 2Organon Canada Inc.
01 22182981
02 22603509
01 4Asenapine
01 4tablet
01 22015-03-01
02 22026-04-06
Patent Expiration Date : 2026-04-06
Date Granted : 2013-12-03
Brand Name : SAPHRIS
Patent Number : 2603509
Filing Date : 2006-04-06
Strength per Unit : 5 mg
Dosage Form : tablet
Human Or VET : Human
Route of Administration : sublingual
Patent Expiration Date : 2026-04-06
Date Granted : 2013-12-03
Patent Expiration Date : 2015-03-01
Date Granted : 2006-10-17
Brand Name : SAPHRIS
Patent Number : 2182981
Filing Date : 1995-03-01
Strength per Unit : 5 mg
Dosage Form : tablet
Human Or VET : Human
Route of Administration : sublingual
Patent Expiration Date : 2015-03-01
Date Granted : 2006-10-17
Patent Expiration Date : 2026-04-06
Date Granted : 2013-12-03
Brand Name : SAPHRIS
Patent Number : 2603509
Filing Date : 2006-04-06
Strength per Unit : 10 mg
Dosage Form : tablet
Human Or VET : Human
Route of Administration : sublingual
Patent Expiration Date : 2026-04-06
Date Granted : 2013-12-03
Patent Expiration Date : 2015-03-01
Date Granted : 2006-10-17
Brand Name : SAPHRIS
Patent Number : 2182981
Filing Date : 1995-03-01
Strength per Unit : 10 mg
Dosage Form : tablet
Human Or VET : Human
Route of Administration : sublingual
Patent Expiration Date : 2015-03-01
Date Granted : 2006-10-17
LOOKING FOR A SUPPLIER?
Market Place
